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Purpose: “Code Blue” is a standard term used to alertt hospital staff that a patient requires 
resuscitation. This study determined rates of survival from Code Blue events and the role of 
opioids and other factors on survival.
Methods: Data derived from medical records and the Code Blue and Pharmacy databases were 
analyzed for factors affecting survival.
Results: During 2006, rates of survival from the code only and to discharge were 25.9% and 
26.4%, respectively, for Code Blue events involving cardiopulmonary resuscitation (CPR; 
N = 216). Survival rates for events not ultimately requiring CPR (N = 77) were higher, with 32.5% 
surviving the code only and 62.3% surviving to discharge. For CPR events, rates of survival to 
discharge correlated inversely with time to chest compressions and defibrillation, precipitating 
event, need for airway management, location and age. Time of week, witnessing, postopera-
tive status, gender and opioid use did not influence survival rates. For non-CPR events, opioid 
use was associated with decreased survival. Survival rates were lowest for patients receiving 
continuous infusions (P  0.01) or iv boluses of opioids (P  0.05).
Conclusions: One-quarter of patients survive to discharge after a CPR Code Blue event and 
two-thirds survive to discharge after a non-CPR event. Opioids may influence survival from 
non-CPR events.
Keywords: code blue, survival, opioids, cardiopulmonary resuscitation, cardiac arrest, patient 
safety
Introduction
“Code Blue” is one of numerous standardized terminologies in the uniform hospital 
code system developed by the Hospital Association of Southern California, United 
States, in 2000 and used to indicate that a patient requires immediate resuscitation.1 
Cardiac arrest is the most common trigger for a Code Blue emergency, but respiratory 
depression and/or hypotension can also serve as precipitating or contributing factors. 
Cardiopulmonary resuscitation (CPR) has been in widespread use as a resuscitation 
technique since scientific evidence of its success was introduced in 1960.2 Research on 
factors that contribute to the effectiveness of CPR is sparse, although several factors 
have been identified, including the time to chest compressions and defibrillation,3–6 
the time of day/week,7 and characteristics such as patient age and gender.8–9
Opioids are commonly used for the treatment of acute pain, particularly in the 
hospital setting. Yet concerns continue to mount related to the safety of opioids, out-
side or within a hospital setting.10–12 Indeed, opioid-induced respiratory depression 
and hypotension are life-threatening complications that can arise quickly and are Therapeutics and Clinical Risk Management 2009:5 962
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not always recognized, even when continuous monitoring 
devices are employed.13–14 The relationship between opioids 
and rates of survival from Code Blue emergencies has not 
been explored.
The aims of this study are to: (1) determine rates of survival 
from Code Blue events and survival to hospital discharge; and, 
(2) explore factors associated with decreased rates of survival 
from Code Blue events, specifically the use of opioids.
Methods
All study procedures were approved by the Institutional 
Review Board at the University of North Carolina (UNC) 
at Chapel Hill (#07-1034).
Primary data sources
The primary data sources were the Department of Patient 
Safety and Performance Improvement’s Code Blue database, 
the Pharmacy Department’s database, and patient medical 
records at UNC Hospitals, a large, university-based, tertiary 
care hospital.
Data extraction and dataset generation
UNC hospitals incorporated many of the “Utstein Style” code 
blue reporting guidelines15 into a standardized Code Blue 
reporting form. The form was completed by the charge 
nurse and verified by the attending physician at the time of 
the Code Blue emergency. The form contained checkboxes 
for the precipitating cause of the event, the hospital loca-
tion, whether the event was witnessed, and whether airway 
management (intubation, positive pressure ventilation, mask 
ventilation) was required. Data on hospital discharge data 
(dead or alive; date) were entered into this database manually, 
after patient follow-up by the database administrator. Included 
in the Code Blue database were events requiring CPR (CPR 
events) and events not requiring CPR but triggered by respi-
ratory depression or hypotension and suspected initially to 
require CPR (non-CPR events). The Code Blue database did 
not contain data on terminal patients receiving palliative care. 
The Code Blue database was queried for all fields of data from 
the year 2006, including patient medical record numbers. The 
Pharmacy Database was queried for all narcotics (drug, route 
of administration, time of administration) administered in 
the 24 hours before each event, using patient medical record 
numbers and the date and time of the event to identify patients. 
Actual narcotic dosages administered to each patient were 
not available in the database. Results from both queries were 
transferred to two separate MS Excel (Microsoft, Inc., Seattle, 
WA) datasets. Data related to patient demographics, diagnoses, 
comorbidities and operative history were extracted from paper 
medical records and manually entered into a third MS Excel 
dataset. SPSS (v. 16.0; SPSS, Inc., Chicago, IL) was used to 
merge the MS Excel datasets and create a new dataset, using 
patient medical record numbers and the dates and times of 
each event as index variables. The resulting dataset was then 
stripped of all identifiers and SPSS was used for data clean-up, 
variable building and variable transformations. A new vari-
able was created to distinguish codes occurring on weekdays 
(Monday 07:00 to Friday 22:59) from those occurring on 
weekends (Friday 23:00 to Monday 06:59), using the same 
definitions as Peberdy et al.7
Primary outcome variables
The primary endpoint variables were patient survival from the 
event (Survived Code Only) and patient survival to hospital 
discharge (Survived to Discharge).
statistical analysis
SPSS (v. 16) was used for statistical analysis. CPR events and 
non-CPR events were analyzed separately. A retrospective 
power analysis indicated that the sample size was sufficient to 
report survival rates for both CPR and non-CPR events with a 
95% confidence level and 10% confidence interval. Descriptive 
statistics were generated and the two survival groups (Survived 
Code Only and Survived to Discharge) were individually 
compared to those who did not survive the code across select 
variables using Chi Square or Fisher’s Exact test for categori-
cal variables or Analysis of Variance for continuous variables. 
Missing data points were excluded from the statistical analysis. 
Data on the relationship between opioids and survival were 
analyzed overall and stratified by route of opioid administration. 
For all analyses, α = 0.05.
Results
Over the one year study period, 222 Code Blue emergency 
calls involved CPR and 83 Code Blue emergency calls 
were non-CPR events precipitated by respiratory depression 
and/or hypotension and suspected initially to require CPR. 
Six of the CPR events and 6 of the non-CPR events took 
place in the Emergency Department and outcomes were 
unknown. These were excluded from further analysis, 
thereby reducing the number of CPR events to 216 and 
non-CPR events to 77.
For CPR events, 56 (25.9%) subjects survived the code 
only and 57 (26.4%) subjects survived to hospital dis-
charge (Table 1). The time to chest compressions (P  0.05) 
and defibrillation (P  0.01) was significantly shorter for Therapeutics and Clinical Risk Management 2009:5 963
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Table 1 survival from cardiopulmonary resuscitation events, overall and by event and demographic characteristicsa
Total 
N = 216
Did not survive 
code  
N = 103 (47.7%)
Survived code 
only  
N = 56 (25.9%)
Pb Survived to 
discharge  
N = 57 (26.4%)
Pb
Mean ± SEM
Time to chest 
compressions
3.13 ± 0.62 4.64 ± 1.32 1.91 ± 1.32 ns 1.92 ± 0.46 0.05
Time to defibrillation 10.76 ± 1.45 14.75 ± 1.95 7.10 ± 1.83 ns 4.14 ± 1.32 0.01
N (%)
Precipitating cause
  Respiratory depression 34 (15.7%) 10 (9.7%) 10 (17.9%) ns 14 (24.6%) 0.01
  hypotension 18 (8.3%) 8 (7.8%) 3 (5.4%) 7 (12.3%)
  Lethal arrhythmia/Mi 39 (18.1%) 20 (19.4%) 13 (23.2%) 6 (10.5%)
  Multiple causes 36 (16.7%) 20 (19.4%) 13 (23.2%) 3 (5.3%)
  Other/unknownc 89 (41.2%) 45 (43.7%) 17 (30.4%) 27 (47.4%)
Location
  niCU/PiCU 35 (16.2%) 10 (9.7%) 7 (12.5%) 0.05 18 (31.6%) 0.0005
  Women’s and children’s 10 (4.6%) 4 (3.9%) 1 (1.8%) 5 (8.8%)
  Cardiac care unit 22 (10.2%) 13 (12.6%) 3 (5.4%) 6 (10.5%)
  iCU 70 (32.4%) 33 (32.0%) 24 (42.9%) 13 (22.8%)
  eD 29 (13.4%) 24 (23.3%) 3 (5.4%) 2 (3.5%)
  Otherd 50 (23.1%) 19 (18.4%) 18 (32.1%) 13 (22.8%)
Witnessed event
  Yes 176 (81.5%) 82 (79.6%) 45 (80.4%) ns 49 (86.0%) ns
  no 30 (13.9%) 17 (16.5%) 7 (12.5%) 6 (10.5%)
  not recorded 10 (4.6%) 4 (3.9%) 4 (7.1%) 2 (3.5%)
Weekend event
  Yes 47 (21.8%) 20 (19.4%) 11 (19.6%) ns 16 (28.1%) ns
  no 128 (59.3%) 58 (56.3%) 37 (66.1%) 33 (57.9%)
  not recorded 41 (19.0%) 25 (24.3%) 8 (14.3%) 8 (14.0%)
Airway management
  Yes 106 (49.1%) 60 (58.3%) 25 (44.6%) ns 21 (36.8%) 0.05
  no 104 (48.1%) 40 (38.8%) 30 (53.6%) 34 (59.6%)
  not recorded 6 (2.8%) 3 (2.9%) 1 (1.8%) 2 (3.5%)
Opioid administration 
within 24 h of event
  Yes 92 (42.6%) 39 (37.9%) 30 (53.6%) ns 23 (40.4%) ns
  no 124 (57.4%) 64 (62.1%) 26 (46.4%) 34 (59.6%)
N = 196 N = 92 N = 54 N = 50
Event 72 h postoperative
  Yes 5 (2.6%) 3 (3.3%) 2 (3.7%) ns 0 (0.0%) ns
  no 191 (97.4%) 89 (96.7%) 52 (96.3%) 50 (100.0%)
Age (years)
  2 35 (17.9%) 8 (8.7%) 8 (14.8%) ns 19 (38.0%) 0.0005
  3–64 100 (51.0%) 53 (57.6%) 25 (46.3%) 22 (44.0%)
  65 61 (31.1%) 31 (33.7%) 21 (38.9%) 9 (18.0%)
Gender
  Male 124 (63.3%) 60 (65.2%) 36 (66.7%) ns 28 (56.0%) ns
  Female 72 (36.7%) 32 (34.8%) 18 (33.3%) 22 (44.0%)
aThe table shows the characteristics of patients who survived or did not survive CPR Code Blue events. Demographic data and data on operative history were missing for 
a subset of patients (n = 26). bThe two survival groups were independently compared to the group who did not survive the event, using Chi square or Fisher’s exact Test for 
categorical values and analysis of variance (student’s t test) for continuous variables.
cThe precipitating cause was listed as Other for 28.1% of events and Unknown for 71.9% of events.
dOther represents hospital floor locations or procedural suites.
Abbreviations: MI, myocardial infarction; NICU/PICU, neonatal or pediatric intensive care unit; ICU, intensive care unit; ED, emergency department; NS, not significant.Therapeutics and Clinical Risk Management 2009:5 964
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those who survived to discharge compared to those who did 
not survive the code. The precipitating cause of the event 
differed for subjects who survived to discharge compared to 
those who did not survive the code (P  0.01). Respiratory 
depression was more common, and lethal rrhythmia/myocar-
dial infarction or multiple causes were less common, among 
those who survived to discharge compared to those who did 
not survive the code. The location of the code also differed for 
those who survived to discharge (P  0.0005). Compared to 
subjects who did not survive the code, subjects who survived 
to discharge were more frequently in the Neonatal Intensive 
Care Unit/Pediatric Intensive Care Unit (NICU/PICU) and less 
frequently in the emergency department. The proportion of 
CPR events that were witnessed or that occurred on weekends 
were similar among subjects who survived to discharge com-
pared to subjects who did not. However, the need for airway 
management was less common among subjects who survived 
to discharge compared to those who did not (P  0.05). The 
use of opioids, postoperative status and gender composition 
was similar among subjects who survived to discharge and 
those who did not survive the code, but subjects who survived 
to discharge had a greater proportion of subjects 2 years 
and a smaller proportion of subjects 65 years (P  0.0005). 
Subjects who survived the code only were similar to those 
who did not survive the code in every examined factor except 
for location. Subjects who survived the code only were more 
likely to be in the NICU/PICU, and less likely to be in the 
emergency department, than those who did not survive the 
code (P  0.05).
Survival rates were higher for non-CPR events (N = 77), 
with 25 (35.2%) subjects surviving the code only and 
48 (62.3%) subjects surviving to discharge (Table 2). Opioid 
use was the only factor that differed among subjects who 
survived compared to subjects who did not survive the code. 
Opioid use was less common among subjects who survived 
to discharge compared to those who did not survive the code 
(P  0.05) and a similar trend was apparent for those who 
survived the code only (P  0.10).
Thirty-three (42.9%) subjects received at least one opioid 
within 24 hours of the non-CPR event (Table 3). Morphine 
and fentanyl were the primary opioids administered and these 
were administered to 4 (5.2%) subjects as continuous infu-
sions, 4 (5.2%) subjects as patient-controlled analgesia (PCA) 
and 8 (10.4%) subjects as iv boluses. Hydromorphone was 
administered as an iv bolus to 1 (1.3%) subject. Oxycodone 
was administered orally to 3 (3.9%) subjects and 13 (16.9%) 
subjects received IV boluses of morphine or fentanyl in 
combination with oral oxycodone. When subjects receiving 
opioids through each route of administration were compared 
to those who did not receive opioids, rates of survival were 
found to be significantly lower among those who received 
continuous infusions or iv boluses of morphine or fentanyl 
(Table 3). None of the subjects who received a continuous 
infusion of morphine or fentanyl survived to hospital dis-
charge compared to 30 (68.2%) subjects who did not receive 
opioids (P  0.001). Rates of survival to hospital discharge 
also were lower for subjects who received iv boluses of 
morphine or fentanyl (P  0.05%). Of note, all patients who 
did not receive opioids survived the code, whereas 50.0% 
of subjects who received continuous infusions, 22.9% of 
subjects who received iv boluses and 15.4% of subjects who 
received iv boluses in combination with oral oxycodone did 
not survive the code. Four subjects (5.2%) received at least 
one injection of naloxone before the non-CPR event and only 
2 of those (50.0%) survived to discharge.
Discussion
While CPR has been formally studied only in the last 
several decades, it has been described in texts that date 
back to Biblical times. Elisha is said to have laid his lips on 
a child’s lifeless body and, with two stretches of his body 
upon the child, brought the child back to life. Modern CPR 
dates back to 1960, when closed chest cardiac massage was 
proven to be beneficial in animal studies,2 and CPR remains 
in widespread use, both in-hospital and out-of-hospital. CPR 
is the first treatment approach taken during an in-hospital 
Code Blue emergency involving cardiac arrest. Systematic 
research on the effectiveness and long-term outcomes of 
different modes of resuscitation began only recently, driven 
in large part by the “Utstein Style” reporting recommenda-
tions of a task force drawn from members of the American 
Heart Association, the European Resuscitation Council, 
the Heart and Stroke Foundation of Canada, the Australian 
Resuscitation Council, and the Resuscitation Council of 
Southern Africa.15 Despite the long history of resuscitation, 
only recently have researchers investigated the effectiveness 
of CPR, in terms of both short- and long-term outcomes, and 
factors contributing to survival.
The primary aim of the present study was to determine 
rates of survival from the Code Blue event only and to hospital 
discharge. A secondary aim was to explore factors influencing 
survival, specifically the use of opioids, as recent concerns 
have been raised regarding the safety of opioids, even in a 
hospital setting with standard continuous monitoring.10–14 We 
emphasize that our Code Blue database does not contain data 
from calls to our Rapid Response Team (RRT, otherwise Therapeutics and Clinical Risk Management 2009:5 965
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Table 2 survival from non-cardiopulmonary resuscitation events, overall and by event and demographic characteristicsa
Total 
N = 77
Did not survive 
code  
N = 4 (5.2%)
Survived code 
only  
N = 25 (32.5%)
Pb Survived to 
discharge  




  Respiratory depression 47 (61.0%) 1 (25.0%) 13 (52.0%) ns 33 (68.8%) ns
  hypotension 15 (19.5%) 1 (25.0%) 4 (16.0%) 10 (20.8%)
  Both 15 (19.5%) 2 (50.0%) 8 (32.0%) 5 (10.4%)
Location
  niCU/PiCU 0 (0.0%) 0 (0.0%) 0 (0.0%) ns 0 (0.0%) ns
  Women’s and children’s 6 (7.8%) 0 (0.0%) 2 (8.0%) 4 (8.3%)
  Cardiac Care Unit 7 (9.1%) 1 (25.0%) 2 (8.0%) 4 (8.3%)
  iCU 29 (37.7%) 3 (75.0%) 11 (44.0%) 15 (31.3%)
  eD 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
  Otherc 35 (45.5%) 0 (0.0%) 10 (40.0%) 25 (52.1%)
Witnessed event
  Yes 66 (85.7%) 4 (100.0%) 23 (92.0%) ns 39 (81.3%) ns
  no 3 (3.9%) 0 (0.0%) 0 (0.0%) 3 (6.3%)
  not recorded 8 (10.4%) 0 (0.0%) 2 (8.0%) 6 (12.5%)
Weekend event
  Yes 22 (28.6%) 2 (50.0%) 9 (36.0%) ns 11 (22.9%) ns
  no 46 (59.7%) 2 (50.0%) 14 (56.0%) 30 (62.5%)
  not recorded 9 (11.7%) 0 (0.0%) 2 (8.0%) 7 (14.6%)
Airway management
  Yes 14 (18.2%) 2 (50.0%) 7 (28.0%) ns 5 (10.4%) ns
  no 62 (80.5%) 2 (50.0%) 18 (72.0%) 42 (87.5%)
  not recorded 1 (1.3%) 0 (0.0%) 0 (0.0%) 1 (2.1%)
Opioid administration 
within 24 h of event
  Yes 33 (42.9%) 4 (100.0%) 11 (44.0%) ns 18 (37.5%) 0.05
  no 44 (57.1%) 0 (0.0%) 14 (56.0%) 30 (62.5%)
N = 75 N = 4 N = 25 N = 46
Event 72 h postoperative
  Yes 3 (4.0%) 0 (0.0%) 1 (4.0%) ns 2 (4.3%) ns
  no 72 (96.0%) 4 (100.0%) 24 (96.0%) 44 (95.7%)
Age (years)
  2 1 (1.3%) 0 (0.0%) 0 (0.0%) ns 1 (2.2%) ns
  3–64 56 (74.7%) 4 (100.0%) 20 (80.0%) 32 (69.6%)
  65 18 (24.0%) 0 (0.0%) 5 (20.0%) 13 (28.3%)
Gender
  Male 39 (52.0%) 3 (75.0%) 11 (44.0%) ns 25 (54.3%) ns
  Female 36 (48.0%) 1 (25.0%) 14 (56.0%) 21 (45.7%)
aThe table shows the characteristics of patients who survived or did not survive respiratory depression- and/or hypotension-precipitated non-CPR Code Blue events. Demo-
graphic data and data on operative history were missing for a subset of patients (n = 2).
bThe two survival groups were independently compared to the group who did not survive the event, using Chi square or Fisher’s exact Test for categorical values and analysis 
of variance (student’s t test) for continuous variables.
cOther represents hospital floor locations or procedural suites.
Abbreviations: MI, myocardial infarction; NICU/PICU, neonatal or pediatric intensive care unit; ICU, intensive care unit; ED, emergency department; NS, not significant.Therapeutics and Clinical Risk Management 2009:5 966
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known as medical emergency team), which was operational 
during the study period, nor does it contain data on terminal 
patients receiving palliative care. Our results indicate that 
26.4% of patients survive to discharge after a CPR event. 
Rates of survival are higher for non-CPR events, with 62.3% 
of patients surviving to discharge. These survival rates are in 
the same range as previously published rates.4–6,16,17
Patients who survived to discharge after a CPR event are 
more likely to be located in the NICU/PICU and be 2 years 
of age, compared to patients who did not survive the code. 
This finding probably relates to the relatively better health 
status of very young children and the plasticity of their 
central nervous system. In addition, the etiology of cardiac 
arrest in children is more frequently respiratory-related, 
rather than cardiac, as is the case in adults.18 Prior studies 
suggest decreased rates of survival from CPR among the 
elderly,9,19,20 although other studies have not found an effect 
of age on survival.16 The findings reported here indicate a 
greater proportion of patients 65 years of age among those 
who did not survive the CPR event compared to those who 
survived to discharge.
Prior studies have shown that females have higher rates 
of survival from cardiac arrest than males,9 although dis-
crepancies exist.21 In the current study, rates of survival from 
CPR events and to hospital discharge were similar among 
males and females. These findings suggest that an innate 
difference between genders in the response to CPR does not 
exist; rather, multiple factors likely contribute to any gender 
disparity in survival.22
The 2005 Advanced Cardiac Life Support guidelines rec-
ommend that chest compressions be started immediately upon 
reaching a Code Blue patient.3 This recommendation is based 
on the results of studies demonstrating that the rapid onset of 
chest compressions increases the odds of survival after cardiac 
arrest. Recent findings also demonstrate a relationship between 
delayed defibrillation and decreased survival after in-hospital 
cardiac arrest.4,5 The present results confirm the importance 
of a rapid onset of chest compressions and defibrillation by 
showing that the time to chest compressions and defibrillation 
is shorter among patients who survive to discharge after a CPR 
event compared to those who did not survive the code. The 
time to chest compressions and defibrillation is influenced 
by numerous factors, including the location of the event, the 
experience level of the responder and other unknown factors.4,5 
Nevertheless, the current findings reinforce the importance of 
rapid action and early resuscitation efforts.
A recent study showed that rates of survival from in hos-
pital cardiac arrest are lower on weekends than on weekdays.7 
The authors suggest that the difference in survival rates is 
related to a difference in hospital staffing on weekends 
compared to weekdays. They also note that the difference is 
much smaller when controlled for the presence or absence 
of continuous respiratory monitors, which are routinely 
deployed in stepdown and intensive care units. In our study, 
the proportion of patients who survived CPR events occurring 
on weekends was similar to those occurring during weekdays, 
which likely reflects the fact that the majority of our patients 
were in a continuously monitored setting and had a witnessed 
cardiac arrests. In the Peberdy et al7 study, the only location in 
which there was no difference in survival between weekends 
and weekdays was in the emergency department, which is in 
agreement with the present findings.
One of the aims of the present study was to explore the 
relationship between opioids and rates of survival from 
Code Blue emergencies. The appropriateness of monitoring 
patients receiving opioids has been called into question by 
Table 3 Route of opioid administration before non-cardiopulmonary resuscitation events (n = 77)a
No opioids 




N = 4 (5.2%)
Pb PCAc 
N = 4 
(5.2%)
Pb IV bolus 
N = 9 
(11.7%)
Pb Oral 
N = 3 
(3.9%)
Pb IV Bolus and 
oral  
N = 13 (16.9%)
Pb
Did not survive 
code
0 (0.0%) 2 (50.0%) 0.001 0 (0.0%) ns 2 (22.2%) 0.05 0 (0.0%) ns 2 (15.4%) ns
survived code 
only
14 (31.8%) 2 (50.0%) 2 (50.0%) 2 (22.2%) 1 (33.3%) 3 (23.1%)
survived to 
discharge
30 (68.2%) 0 (0.0%) 2 (50.0%) 5 (55.6%) 2 (66.7%) 8 (61.5%)
aThe table shows opioid use by route of administration within 24 hours of respiratory depression- and hypotension-precipitated non-CPR events. Patients received morphine 
or fentanyl by continuous infusion, PCA or iv bolus. One patient received hydromorphone by an iv bolus and oral oxycodone (with or without iv boluses) was administered 
alone to 3 patients and in combination with iv boluses of morphine or fentanyl to 13 patients.
bsurvival rates among subjects who received opioids by each route of administration were compared to those among subjects who did not receive opioids using Chi square 
or Fisher’s exact Test.
cPatients receiving opioids by PCA also received iv boluses.
Abbreviations: PCA, patient-controlled analgesia; NS, not significant.Therapeutics and Clinical Risk Management 2009:5 967
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a number of investigators.10–14,23 A relationship between 
opioids and survival from CPR events was not found. 
However, for non-CPR events, opioids were the only factor 
found to influence survival. Patients who survived to dis-
charge were less likely to have received opioids within 24 
hours of the non-CPR event compared to those who did not 
survive the code. Interestingly, 4 (5.2%) patients received 
naloxone within 24 hours of the non-CPR event, presum-
ably for suspected respiratory depression. Morphine and 
fentanyl were the most common opioids and administration 
by continuous infusion or iv bolus was found to influence 
survival. More patients did not survive the code and fewer 
subjects survived to discharge among patients receiving 
continuous infusions or iv boluses, compared to those who 
did not receive opioids. The reason(s) underlying this asso-
ciation is unclear. All of the patients receiving continuous 
infusions or iv boluses were in an ICU location equipped 
with standard continuous monitors. An interesting possibil-
ity is that patients who received continuous infusions of 
opioids were on chronic narcotics prior to admission to the 
hospital, as this is a common practice in these patients who 
are difficult pain control cases. Recent data suggests these 
patients may have more frequent central apneas and ataxic 
breathing patterns that may predispose them to postoperative 
respiratory complications.24
Limitations
The present study has several limitations that should be 
considered when interpreting the results. First, the data are 
derived from a Code Blue reporting form that is completed 
by charge nurses at the scene of the event. The form is used 
primarily for clinical purposes and the nurses completing the 
form are not trained to collect the data for research purposes; 
therefore, inaccuracies are possible. Second, the possibility 
exists that some of the events were misclassified as cardiac 
arrests. Such cases could not be differentiated in the dataset. 
Third, the data on opioid use are derived from the Pharmacy 
database which is used primarily for billing and legal pur-
poses, not research, and so inaccuracies are possible and the 
data are limited; for example, the exact dosages patients were 
administered were not available for analysis. Furthermore, 
the reported rates of opioid use are likely lower than actual 
rates because data on patients who had PCA or continuous 
infusions of opioids initiated 24 hours before the event 
were not captured. Finally, our finding related to opioid use 
and survival from non-CPR events should be considered 
preliminary until assessed more rigorously in a study specifi-
cally designed to evaluate this association.
Conclusions
At our large, university-based, tertiary care hospital, 
approximately one-quarter of patients survive to discharge 
after a CPR Code Blue Event and nearly two-thirds of 
patients survive to discharge after a non-CPR Code Blue 
Event. Survival from CPR events is inversely correlated 
with the time to chest compressions and defibrillation and 
the need for airway management. CPR events precipitated by 
respiratory depression and occurring among patients in the 
NICU/PICU or 2 years of age have higher rates of survival. 
Survival from CPR events is not influenced by time of week, 
witnessing, postoperative status, gender or the use of opioids. 
Survival from non-CPR events appears to be influenced by 
the use of opioids within 24 hours of the event.
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